|
Name: N-Ethyl-3-piperidyl benzilate
Type: Anticholinergic
AKA: JB 323
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
N-ethyl-3-piperidyl benzilate, a synthetic compound, was developed for research purposes. It is studied for its effects on the central nervous system and potential medical uses.
|
|
V. Legal Information
N-Ethyl-3-piperidyl Benzilate is a synthetic compound with stimulant properties. It is controlled under various drug laws due to its potential for abuse. In the United States, it may be regulated under new psychoactive substances legislation, with similar controls globally. [Source: UNODC].
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
N-Ethyl-3-piperidyl benzilate is a synthetic compound with potential psychoactive effects. Short-term use may induce euphoria and altered perception, but long-term use poses risks of psychological issues and cardiovascular effects. Overdose risks include severe agitation and cardiovascular issues. Safe use requires careful dosing and monitoring. Recent research explores its psychoactive properties and associated health risks.  |
|
VII. Psychological Effects
This compound has anticholinergic properties, leading to effects like sedation and mood changes. Long-term use can cause cognitive impairments and psychological disturbances. Research focuses on its impact on neurotransmitter systems and associated risks.
 |
|
VIII. Culture
N-Ethyl-3-piperidyl benzilate is a potent anticholinergic causing hallucinogenic effects, classifying it as a deliriant. Short-term use induces delirium, hallucinations, and confusion, while long-term use is not well-documented due to its high risk of toxicity. Overdose can result in severe agitation, hyperthermia, and cardiovascular complications. Safe dosages are not well-established, with lower doses advised. Recent research focuses on its abuse potential and health risks. Physical signs include dilated pupils, increased heart rate, and elevated blood pressure.
 |